Literature DB >> 6880604

The epidemiology of multiple sclerosis in Finland: increase of prevalence and stability of foci in high-risk areas.

E Kinnunen, J Wikström, J Porras, J Palo.   

Abstract

Reliable data on the epidemiology of multiple sclerosis (MS) in Finland are available from 1964 and 1972. They show that the whole country is a high-risk area of MS with clustering in the western part. A reassessment of the prevalence data was carried out in the southern province of Uusimaa and in the western province of Vaasa, the prevalence day being January 1, 1979. The age-adjusted prevalence was 52.9 per 100,000 in Uusimaa and 92.9 per 100,000 in Vaasa, figures that were three times higher than those recorded for the same areas in 1964. The communities with the highest prevalence rates in the province of Vaasa were the same as those in the survey of 1972; some rates exceeded 200 per 100,000. The increase in the prevalence rates may be due to a better registration of MS cases, but it may also represent a true increase, a possibility that only can be answered by further incidence studies.

Entities:  

Mesh:

Year:  1983        PMID: 6880604     DOI: 10.1111/j.1600-0404.1983.tb04574.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

1.  Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.

Authors:  M-L Sumelahti; P J Tienari; M Hakama; J Wikström
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Regional differences in the incidence of rheumatoid arthritis in Finland in 1995.

Authors:  O Kaipiainen-Seppänen; K Aho; M Nikkarinen
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

Review 3.  A review of the etiology of multiple sclerosis.

Authors:  V Vella
Journal:  Ital J Neurol Sci       Date:  1984-12

4.  Genomewide scan of multiple sclerosis in Finnish multiplex families.

Authors:  S Kuokkanen; M Gschwend; J D Rioux; M J Daly; J D Terwilliger; P J Tienari; J Wikström; J Palo; L D Stein; T J Hudson; E S Lander; L Peltonen
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

5.  Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS.

Authors:  Suvi P Kallio; Eveliina Jakkula; Shaun Purcell; Minna Suvela; Keijo Koivisto; Pentti J Tienari; Irina Elovaara; Tuula Pirttilä; Mauri Reunanen; Denis Bronnikov; Markku Viander; Seppo Meri; Jan Hillert; Frida Lundmark; Hanne F Harbo; Aslaug R Lorentzen; Philip L De Jager; Mark J Daly; David A Hafler; Aarno Palotie; Leena Peltonen; Janna Saarela
Journal:  Hum Mol Genet       Date:  2009-02-16       Impact factor: 6.150

6.  Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings.

Authors:  P J Tienari; O Salonen; J Wikström; L Valanne; J Palo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.